Perceptive Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-26,000
Closed -$3.01M 236
2016
Q4
$3.01M Buy
+26,000
New +$2.9M 0.21% 71
2016
Q2
Sell
-50,000
Closed -$5M 226
2016
Q1
$5M Buy
+50,000
New +$5.15M 0.44% 56
2015
Q2
Sell
-29,967
Closed -$3.46M 209
2015
Q1
$3.46M Sell
29,967
-116,600
-80% -$13.9M 0.27% 67
2014
Q4
$16.4M Sell
146,567
-230,881
-61% -$24.3M 1.37% 23
2014
Q3
$35.8M Sell
377,448
-130,040
-26% -$11.7M 3.62% 6
2014
Q2
$43.6M Buy
507,488
+95,088
+23% +$7.23M 4.28% 5
2014
Q1
$28.8M Sell
412,400
-606,000
-60% -$48M 3.02% 6
2013
Q4
$86M Buy
1,018,400
+289,162
+40% +$22.9M 10.33% 1
2013
Q3
$56.2M Buy
729,238
+536,726
+279% +$37.6M 4.56% 6
2013
Q2
$11.3M Buy
+192,512
New +$11.6M 1.14% 19

Other funds holding CELG

Perceptive Advisors's CELG Position: Q1 2017 in Review

Perceptive Advisors sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 26,000 shares — an estimated $3.01M sold.

Perceptive Advisors first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $86M in Q4 2013. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Perceptive Advisors reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Perceptive Advisors sold 26,000 Celgene Corp shares in Q1 2017, an estimated $3.01M.
  • Perceptive Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • Perceptive Advisors's Celgene Corp position peaked at $86M in Q4 2013.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.